None listed
Conditions
Interventions
Drug : Each researcher conducts 7 or 14 days quadruple therapy with ilaprazole, bismuth, metronidazole, and tetracycline to their patient who has a peptic ulcer including scars and clarithromycin-resi
Sponsors
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Patients over 19 year and below 75 year - Patients with clarithromycin-resistant H. pylori-positive according to results of Dual Priming Oligonucleotide-Based Multiplex Polymerase Chain Reaction and biopsy - Patients who agree to participate in this clinical trial and sign voluntarily - Patients who don’t have dementia or cognitive impairment
Exclusion criteria
Exclusion criteria: - Those with the history of administration with other antibiotic within 1 month. - The highly sensitive person to experimental drug - Those who has undergone upper gastrointestinal surgery - Those who take anticoagulant or steroids - Liver disorder or renal disorder patients - Pregnant or lactating women or childbearing women suspected pregnant - Alcohol addictor or those with the history of drug abuse - Those who participated in other clinical trial within 6 months before this clinical trial - Those who are judged to be improper for this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urea breath test | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse events | — |
Countries
Korea, Republic of
Contacts
Public ContactChulhyun Lim
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
Outcome results
None listed